NCT02450097View on ClinicalTrials.gov

Metabolic and Hormonal Effects of 5:2 Intermittent Fasting

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

November 30, 2017

Study Completion Date

December 31, 2017

Conditions
ObesityDiabetes Type 2
Interventions
OTHER

Caloric restriction

Trial Locations (1)

17176

Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska University Hospital

OTHER

NCT02450097 - Metabolic and Hormonal Effects of 5:2 Intermittent Fasting | Biotech Hunter | Biotech Hunter